Torus palatinus osteonecrosis related to bisphosphonate: a case report

dc.creatorGodinho, Mariana
dc.creatorBarbosa, Fabio
dc.creatorAndrade, Felipe
dc.creatorCuzzi, Tullia
dc.creatorRamos-e-Silva, Marcia
dc.date2019-09-18T13:41:19Z
dc.date2019-09-18T13:41:19Z
dc.date2013
dc.date.accessioned2023-09-26T23:03:54Z
dc.date.available2023-09-26T23:03:54Z
dc.identifierGODINHO, Mariana et al. Torus palatinus osteonecrosis related to bisphosphonate: a case report. Case Reports in Dermatology, v. 5, p. 120-125, 2013.
dc.identifier1662-6567
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/35654
dc.identifier10.1159/000350674
dc.identifier1662-6567
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8886431
dc.descriptionTullia Cuzzi. Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.
dc.descriptionIntroduction: Osteonecrosis of the palate is a rare condition which is even rarer when occurring on a torus palatinus and associated with bisphosphonate (BP). Case Presentation: We report an uncommon case of osteonecrosis of a torus palatinus. Our patient was a 67-year-old white female who presented with a painful intraoral ulcer associated with necrotic bone tissue of her torus palatinus, due to the chronic use of alendronate. Conclusion: We point out the possible causative relationship of BPs and osteonecrosis on torus growth. It is very important to know that torus palatinus and the use of BPs are risk factors for osteonecrosis of the maxilla.
dc.formatapplication/pdf
dc.languageeng
dc.publisherKarger Publishers Open Access
dc.rightsopen access
dc.subjectOsteonecrosis
dc.subjectTorus palatinus
dc.subjectBisphosphonates
dc.titleTorus palatinus osteonecrosis related to bisphosphonate: a case report
dc.typeArticle


Este ítem pertenece a la siguiente institución